Marketing "Gifts": How Merck Sold Vioxx

While I was reviewing this awesome piece about Merck's marketing tactics behind pushing Vioxx in today's New York Times, I was struck by the company's strategic use of a physician "hit list," promotional activities and huge amolunts of cash to neutralize its prime competitor, Celebrex. And, I suspect, largely because G.D. Searle's Celebrex beat Merck to the market. The Times obtained a plethora of documents from a public official, including e-mail messages, memorandums and...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports